These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27270756)

  • 1. Clinicopathological characteristics predict lymph node metastases in ypT0-2 rectal cancer after chemoradiotherapy.
    Bosch SL; Vermeer TA; West NP; Swellengrebel HA; Marijnen CA; Cats A; Verhoef C; van Lijnschoten I; de Wilt JH; Rutten HJ; Nagtegaal ID
    Histopathology; 2016 Nov; 69(5):839-848. PubMed ID: 27270756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can clinicopathological parameters predict for lymph node metastases in ypT0-2 rectal carcinoma? Results of the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 phase 3 trials.
    von den Grün JM; Hartmann A; Fietkau R; Ghadimi M; Liersch T; Hohenberger W; Weitz J; Sauer R; Wittekind C; Ströbel P; Rödel C; Fokas E;
    Radiother Oncol; 2018 Sep; 128(3):557-563. PubMed ID: 29929861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].
    Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M
    Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The surgical significance of residual mucosal abnormalities in rectal cancer following neoadjuvant chemoradiotherapy.
    Smith FM; Chang KH; Sheahan K; Hyland J; O'Connell PR; Winter DC
    Br J Surg; 2012 Jul; 99(7):993-1001. PubMed ID: 22351592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.
    Park IJ; You YN; Skibber JM; Rodriguez-Bigas MA; Feig B; Nguyen S; Hu CY; Chang GJ
    Dis Colon Rectum; 2013 Feb; 56(2):135-41. PubMed ID: 23303140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological factors predict residual lymph node metastasis in locally advanced rectal cancer with ypT0-2 after neoadjuvant chemoradiotherapy.
    Cui Y; Song M; Tie J; Li S; Wang H; Zhang Y; Geng J; Liu Z; Teng H; Sui X; Zhu X; Cai Y; Li Y; Wang W
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):176. PubMed ID: 38575793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodal Disease in Rectal Cancer Patients With Complete Tumor Response After Neoadjuvant Chemoradiation: Danger Below Calm Waters.
    Baucom RB; Maguire LH; Kavalukas SL; Geiger TM; Ford MM; Muldoon RL; Hopkins MB; Hawkins AT
    Dis Colon Rectum; 2017 Dec; 60(12):1260-1266. PubMed ID: 29112561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI-based parameters and clinical risk factors to predict lymph node metastasis in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy.
    Wang Y; Wang X; Huang S; Chen J; Huang Y
    ANZ J Surg; 2024 Jun; 94(6):1127-1132. PubMed ID: 38251776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response.
    Belluco C; Forlin M; Olivieri M; Cannizzaro R; Canzonieri V; Buonadonna A; Bidoli E; Matrone F; Bertola G; De Paoli A
    Ann Surg Oncol; 2016 Dec; 23(13):4302-4309. PubMed ID: 27489059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting stage ypT0-1N0 for locally advanced rectal cancer following preoperative chemoradiotherapy: implications for potential candidates of organ-sparing management.
    Huang SH; Chi P; Lin HM; Lu XR; Huang YW; Xu ZB; Sun YW; Ye DX; Wang XJ; Wang X
    Colorectal Dis; 2016 Oct; 18(10):989-996. PubMed ID: 26880193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup.
    Sprenger T; Rothe H; Conradi LC; Beissbarth T; Kauffels A; Kitz J; Homayounfar K; Wolff H; Ströbel P; Ghadimi M; Wittekind C; Sauer R; Rödel C; Liersch T
    Dis Colon Rectum; 2016 May; 59(5):377-85. PubMed ID: 27050599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmetastatic ypt0 rectal cancer after neoadjuvant treatment and total mesorectal excision: Lessons from a retrospective multicentric cohort of 383 patients.
    Collard MK; Rullier E; Panis Y; Manceau G; Benoist S; Tuech JJ; Alves A; Laforest A; Mege D; Cazelles A; Beyer-Berjot L; Christou N; Cotte E; Lakkis Z; O'Connell L; Parc Y; Piessen G; Lefevre JH;
    Surgery; 2022 May; 171(5):1193-1199. PubMed ID: 35078629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic outcome after preoperative chemoradiotherapy in patients with pathologic T0 (ypT0) rectal cancer.
    Jang TY; Yu CS; Yoon YS; Lim SB; Hong SM; Kim TW; Kim JH; Kim JC
    Dis Colon Rectum; 2012 Oct; 55(10):1024-31. PubMed ID: 22965400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications for selecting local excision in locally advanced rectal cancer after preoperative chemoradiation.
    Wan J; Liu K; Zhu J; Li G; Zhang Z
    Oncotarget; 2015 May; 6(13):11714-22. PubMed ID: 25909169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional lymph node status after neoadjuvant chemoradiation of rectal cancer producing a complete or near complete rectal wall response.
    Shwaartz C; Haim N; Rosin D; Lawrence Y; Gutman M; Zmora O
    Colorectal Dis; 2015 Jul; 17(7):595-9. PubMed ID: 25605475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes.
    Figueiredo N; Panteleimonitis S; Popeskou S; Cunha JF; Qureshi T; Beets GL; Heald RJ; Parvaiz A
    Eur J Surg Oncol; 2018 Apr; 44(4):484-489. PubMed ID: 29398323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
    Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
    Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
    Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node metastases in rectal cancer after preoperative radiochemotherapy: impact of intramesorectal distribution and residual micrometastatic involvement.
    Sprenger T; Rothe H; Becker H; Beissbarth T; Homayounfar K; Gauss K; Kitz J; Wolff H; Scheel AH; Ghadimi M; Rödel C; Conradi LC; Liersch T
    Am J Surg Pathol; 2013 Aug; 37(8):1283-9. PubMed ID: 23851331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A scoring system basing pathological parameters to predict regional lymph node metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer: implication for local excision.
    Wang XJ; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX; Yu Q
    Oncotarget; 2016 Nov; 7(48):78487-78498. PubMed ID: 27489356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.